1.445  0.105 (7.84%)		04-10 10:32
Open: 1.38 High: 1.445 Volume: 2		Pre. Close: 1.34 Low: 1.38 Market Cap: 2(M)

Short term
Mid term
Targets	6-month :	2.18	1-year :	2.6
Resists	First :	1.87	Second :	2.22
Pivot price	1.46
Supports	First :	1.29	Second :	1.08
MAs	MA(5) :	1.34	MA(20) :	1.52
	MA(100) :	2.39	MA(250) :	3.39
MACD	MACD :	-0.2	Signal :	-0.2
%K %D	K(14,3) :	14.4	D(3) :	7.3
RSI	RSI(14): 42.1
52-week	High :	6.71	Low :	1.29

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ RKDA ] has closed above bottom band by 46.7%. Bollinger Bands are 17.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	1.39 - 1.4	1.4 - 1.4
Low:	1.33 - 1.33	1.33 - 1.34
Close:	1.33 - 1.34	1.34 - 1.35

Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.

Tue, 07 Apr 2026
RKDA Stock Price, Quote & Chart | ARCADIA BIOSCIENCES INC (NASDAQ:RKDA) - ChartMill

Thu, 26 Mar 2026
Arcadia Biosciences: Q4 Earnings Snapshot - KING5.com

Thu, 26 Mar 2026
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights - Bitget

Thu, 26 Mar 2026
Arcadia Biosciences: Q4 Earnings Snapshot - KTEN

Thu, 26 Mar 2026
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights - GlobeNewswire

Thu, 26 Mar 2026
Arcadia drops Roosevelt deal, turns to Zola growth and $2.1M cash - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Basic Materials
Industry: Agricultural Inputs
Shares Out	2 (M)
Shares Float	1 (M)
Held by Insiders	0.5 (%)
Held by Institutions	1.8 (%)
Shares Short	24 (K)
Shares Short P.Month	16 (K)

EPS	-1.72
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	3.98
Profit Margin	-98 %
Operating Margin	-88.5 %
Return on Assets (ttm)	-31.5 %
Return on Equity (ttm)	-64.7 %
Qtrly Rev. Growth	-15.4 %
Gross Profit (p.s.)	1.2
Sales Per Share	2.98
EBITDA (p.s.)	-3.44
Qtrly Earnings Growth	0 %
Operating Cash Flow	-6 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-0.85
PEG Ratio	0
Price to Book value	0.36
Price to Sales	0.48
Price to Cash Flow	-0.42

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.